Trial Profile
Adjuvant Colon Cancer With ELOXatin/5 FU Based Regimen: ACCELOX.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Oxaliplatin (Primary)
- Indications Colon cancer
- Focus Therapeutic Use
- Acronyms ACCELOX
- 24 Feb 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 15 Mar 2011 New trial record